FDA Modernization Act 3.0
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 10, 2025)
FDA Modernization Act 3.0
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications.
The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
What just happenedJul 21, 2026
Received in the Senate.
Who’s behind it
- Engrossed in HouseJul 20, 2026
- Reported in HouseJun 18, 2026
- Introduced in HouseApr 10, 2025
- Jul 21, 2026IntroReferral
Received in the Senate.
- Jul 20, 2026FloorH38310
Motion to reconsider laid on the table Agreed to without objection.
- Jul 20, 2026FloorH37300
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Jul 20, 2026Floor8000
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
- Jul 20, 2026FloorH8D000
DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
- Jul 20, 2026FloorH30000
Considered under suspension of the rules. (consideration: CR H4639-4640)
- Jul 20, 2026FloorH30300
Mr. Guthrie moved to suspend the rules and pass the bill.
- Jun 18, 2026CalendarsH12410
Placed on the Union Calendar, Calendar No. 614.
- Jun 18, 2026CommitteeH12200
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
Energy and Commerce Committee - Jun 18, 2026Committee5000
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
Energy and Commerce Committee - May 21, 2026Committee
Ordered to be Reported by the Yeas and Nays: 44 - 0.
Energy and Commerce Committee - May 21, 2026Committee
Committee Consideration and Mark-up Session Held
Energy and Commerce Committee - May 13, 2026Committee
Forwarded by Subcommittee to Full Committee by Voice Vote.
Health Subcommittee - May 13, 2026Committee
Subcommittee Consideration and Mark-up Session Held
Health Subcommittee - Apr 10, 2026Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 10, 2025IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 10, 2025IntroReferralIntro-H
Introduced in House
- Apr 10, 2025IntroReferral1000
Introduced in House